SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-24-068674
Filing Date
2024-06-05
Accepted
2024-06-05 16:08:06
Documents
1
Period of Report
2024-06-03

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2416457-2_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm2416457-2_4seq1.xml 4 9328
  Complete submission text file 0001104659-24-068674.txt   10819
Mailing Address C/O FIVE PRIME THERAPEUTICS, INC. TWO CORPORATE DRIVE SOUTH SAN FRANCISCO CA 94080
Business Address
Hambleton Julie (Reporting) CIK: 0001578771 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39044 | Film No.: 241022056

Mailing Address 100 WASHINGTON BOULEVARD STAMFORD CT 06902
Business Address 100 WASHINGTON BOULEVARD STAMFORD CT 06902 203-883-9490
SpringWorks Therapeutics, Inc. (Issuer) CIK: 0001773427 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)